持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/10 | 3,125 | 3,175 | 3,090 | 3,155 | +30 | +1% | 45,000 |
| 2022/11/09 | 3,140 | 3,165 | 3,125 | 3,125 | +10 | +0.3% | 41,600 |
| 2022/11/08 | 3,115 | 3,135 | 3,065 | 3,115 | +15 | +0.5% | 73,200 |
| 2022/11/07 | 3,240 | 3,250 | 3,095 | 3,100 | -140 | -4.3% | 121,300 |
| 2022/11/04 | 3,430 | 3,440 | 3,215 | 3,240 | -210 | -6.1% | 128,800 |
| 2022/11/02 | 3,405 | 3,480 | 3,405 | 3,450 | +50 | +1.5% | 69,300 |
| 2022/11/01 | 3,430 | 3,465 | 3,390 | 3,400 | -25 | -0.7% | 20,500 |
| 2022/10/31 | 3,400 | 3,455 | 3,385 | 3,425 | +55 | +1.6% | 55,700 |
| 2022/10/28 | 3,350 | 3,405 | 3,345 | 3,370 | -20 | -0.6% | 185,000 |
| 2022/10/27 | 3,405 | 3,425 | 3,365 | 3,390 | -35 | -1% | 38,500 |
| 2022/10/26 | 3,370 | 3,440 | 3,370 | 3,425 | +45 | +1.3% | 35,400 |
| 2022/10/25 | 3,365 | 3,395 | 3,345 | 3,380 | +45 | +1.3% | 34,200 |
| 2022/10/24 | 3,405 | 3,410 | 3,325 | 3,335 | -30 | -0.9% | 63,000 |
| 2022/10/21 | 3,425 | 3,430 | 3,355 | 3,365 | -85 | -2.5% | 44,300 |
| 2022/10/20 | 3,430 | 3,455 | 3,415 | 3,450 | -20 | -0.6% | 28,700 |
| 2022/10/19 | 3,465 | 3,490 | 3,455 | 3,470 | +10 | +0.3% | 28,800 |
| 2022/10/18 | 3,485 | 3,490 | 3,445 | 3,460 | +20 | +0.6% | 33,300 |
| 2022/10/17 | 3,490 | 3,490 | 3,440 | 3,440 | -60 | -1.7% | 28,400 |
| 2022/10/14 | 3,460 | 3,520 | 3,435 | 3,500 | +100 | +2.9% | 43,800 |
| 2022/10/13 | 3,410 | 3,415 | 3,385 | 3,400 | -10 | -0.3% | 29,600 |
| 2022/10/12 | 3,390 | 3,425 | 3,380 | 3,410 | +20 | +0.6% | 30,500 |
| 2022/10/11 | 3,420 | 3,460 | 3,380 | 3,390 | -75 | -2.2% | 38,700 |
| 2022/10/07 | 3,425 | 3,485 | 3,410 | 3,465 | -5 | -0.1% | 38,100 |
| 2022/10/06 | 3,490 | 3,530 | 3,470 | 3,470 | -20 | -0.6% | 55,400 |
| 2022/10/05 | 3,500 | 3,525 | 3,480 | 3,490 | -5 | -0.1% | 41,600 |
| 2022/10/04 | 3,435 | 3,515 | 3,435 | 3,495 | +130 | +3.9% | 59,400 |
| 2022/10/03 | 3,335 | 3,380 | 3,310 | 3,365 | -10 | -0.3% | 51,700 |
| 2022/09/30 | 3,375 | 3,415 | 3,350 | 3,375 | -5 | -0.1% | 40,500 |
| 2022/09/29 | 3,300 | 3,400 | 3,285 | 3,380 | +110 | +3.4% | 54,400 |
| 2022/09/28 | 3,225 | 3,280 | 3,215 | 3,270 | +10 | +0.3% | 45,700 |
| 2022/09/27 | 3,275 | 3,320 | 3,260 | 3,260 | -30 | -0.9% | 41,600 |
| 2022/09/26 | 3,355 | 3,360 | 3,280 | 3,290 | -60 | -1.8% | 45,900 |
| 2022/09/22 | 3,335 | 3,375 | 3,325 | 3,350 | -10 | -0.3% | 32,700 |
| 2022/09/21 | 3,325 | 3,375 | 3,325 | 3,360 | -35 | -1% | 33,100 |
| 2022/09/20 | 3,380 | 3,405 | 3,365 | 3,395 | +25 | +0.7% | 33,200 |
| 2022/09/16 | 3,345 | 3,395 | 3,345 | 3,370 | +25 | +0.7% | 36,800 |
| 2022/09/15 | 3,365 | 3,370 | 3,340 | 3,345 | -15 | -0.4% | 28,400 |
| 2022/09/14 | 3,330 | 3,375 | 3,330 | 3,360 | -80 | -2.3% | 31,900 |
| 2022/09/13 | 3,450 | 3,460 | 3,435 | 3,440 | -5 | -0.1% | 17,500 |
| 2022/09/12 | 3,455 | 3,460 | 3,420 | 3,445 | +20 | +0.6% | 24,000 |
| 2022/09/09 | 3,400 | 3,450 | 3,400 | 3,425 | +30 | +0.9% | 49,400 |
| 2022/09/08 | 3,330 | 3,410 | 3,330 | 3,395 | +115 | +3.5% | 63,100 |
| 2022/09/07 | 3,310 | 3,330 | 3,265 | 3,280 | -30 | -0.9% | 37,700 |
| 2022/09/06 | 3,390 | 3,410 | 3,310 | 3,310 | -65 | -1.9% | 29,300 |
| 2022/09/05 | 3,355 | 3,375 | 3,310 | 3,375 | +15 | +0.4% | 35,700 |
| 2022/09/02 | 3,410 | 3,410 | 3,345 | 3,360 | -20 | -0.6% | 34,000 |
| 2022/09/01 | 3,400 | 3,400 | 3,345 | 3,380 | -55 | -1.6% | 50,000 |
| 2022/08/31 | 3,370 | 3,450 | 3,370 | 3,435 | +20 | +0.6% | 92,000 |
| 2022/08/30 | 3,370 | 3,420 | 3,370 | 3,415 | +45 | +1.3% | 35,000 |
| 2022/08/29 | 3,330 | 3,380 | 3,330 | 3,370 | -40 | -1.2% | 44,300 |
501～
550
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
